Vimarsana
Biggest News Aggregation in the World

Page 28 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Therapy Today - Breaking & Trending Today

Magic mushrooms to improve mental health are coming to NJ - Vimarsana News

Magic mushrooms to improve mental health are coming to NJ

They want to understand the nitty-gritty of helping people with depression in the real world.

Source: nj1015.com
Revive Therapeutics Ltd. Announces Offering of Up to $3 Million - Revive Therapeutics (OTC:RVVTF) - Vimarsana News

Revive Therapeutics Ltd. Announces Offering of Up to $3 Million - Revive Therapeutics (OTC:RVVTF)

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- REVIVE

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. - Tonix Pharmaceuticals (NASDAQ:TNXP) - Vimarsana News

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. - Tonix Pharmaceuticals (NASDAQ:TNXP)

CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates,

ADC Drug Candidate Enters Phase 3 Trial for the Treatment of HER2-Low Breast Cancer - Vimarsana News

ADC Drug Candidate Enters Phase 3 Trial for the Treatment of HER2-Low Breast Cancer

The candidate has already demonstrated anti-tumor activity in chemotherapy-naïve patients.

Revive Therapeutics Ltd. Announces Offering of Up to $3 - Vimarsana News

Revive Therapeutics Ltd. Announces Offering of Up to $3

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED...